Stock Market & Financial Investment News

News Breaks March 5, 2013 06:18 EDT IPXL Impax downgraded to Market Perform from Outperform at Leerink Leerink downgraded Impex following further manufacturing deficiencies at its Hayward facility uncovered by the FDA. Price target lowered to $16 from $23. News For IPXL From The Last 14 Days Check below for free stories on IPXL the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for IPXL Sign up for a free trial to see the rest of the stories you've been missing.